Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Creutzfeldt-Jakob Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Creutzfeldt-Jakob Syndrome in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Creutzfeldt-Jakob Syndrome: A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burdon, DW1

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Creutzfeldt-Jakob Syndrome

ArticleYear
A novel replicating agent isolated from the human intestinal tract having characteristics shared with Creutzfeldt-Jakob and related agents.
    Journal of medical microbiology, 1989, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Creutzfeldt-Jakob Syndrome; Culture Media; Desiccation; Detergents; Disinfect

1989